SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-084633
Filing Date
2021-06-23
Accepted
2021-06-23 16:16:18
Documents
1
Period of Report
2021-06-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120293-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2120293-1_4seq1.xml 4 9863
  Complete submission text file 0001104659-21-084633.txt   11826
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 211038863

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 211038862

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations